Merck to face Billions in Lawsuits

October 2, 2004 - Merck could face legal liabilities of up to $10B following its worldwide withdrawal of the blockbuster pain drug Vioxx, according to some analysts' estimates. Read More

A Blow to Efforts to Close in on Rivals

October 1, 2004 - Merck & Company's decision to stop selling the painkiller Vioxx, one of its most profitable drugs, could hardly have come at a worse time for the company. Read More

Merck estimates $2.5B impact from pulling Vioxx

October 1, 2004 - Merck ended the life of a pain-relief drug that was part of the most successful product launch in history when it hit the market in 1999. Read More

News on Vioxx: A Shot in the Arm for Plaintiffs Bar

October 1, 2004 - The plaintiffs bar was heartened when pharmaceutical giant Merck & Co. stopped sales of Vioxx, a popular arthritis drug that relieves aches and pains, but increases the risk of heart... Read More

Merck withdraws Arthritis Drug Vioxx

September 30, 2004 - Merck & Co. withdrew its arthritis drug Vioxx globally after a colon cancer trial confirmed long-standing concerns the drug raises the risk of heart attack and stroke. Read More

Merck recalls Vioxx

September 30, 2004 - A new FDA study found patients taking a high dose of Vioxx were three times more likely to have a heart attack. As a result, Merck & Co. is pulling the arthritis drug from the market. Read More

Recall of Vioxx after Study Shows New Risk

September 30, 2004 - Merck and Co. said it was voluntarily withdrawing its arthritis and pain medication Vioxx effective immediately after a study revealed an increased relative risk for cardiovascular... Read More

Merck pulls arthritis drug Vioxx

September 30, 2004 - In one of the largest prescription drug recalls in U.S. history, worldwide sales of the popular arthritis drug Vioxx were halted today after new data pointed to an increased patient risk... Read More

Merck withdraws Vioxx

September 30, 2004 - Merck & Co. faces a rocky future after withdrawing its blockbuster arthritis pain drug Vioxx, a high-margin product that had accounted for almost 20% of its profit. Read More

Vioxx linked to Increased Risk of Heart Attacks

September 2, 2004 - Taking more than 25 mg per day of Vioxx is linked to a tripling of the risk of heart attack, said a paper presented in the International Society for Pharmacoepidemiology Conference in... Read More

back to top